Tuberculosis Antibiotic Resistance

The World Health Organisation reported there were more than 10 million new cases of TB in 2019, resulting in 1.4 million deaths making tuberculosis the number 1 cause of death from an infectious disease

About one-quarter of the world's population has a tuberculosis infection and approximately 10% of the United States population have tested positive

Treatment requires the use of 4 antibiotics over a period of 6 months but antibiotic resistance is a growing problem with increasing rates of multiple drug-resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) cases, which sometimes need 2 years of drug treatment and in the worst cases, even chemotherapy

Worldwide, only 57% of MDR-TB patients are currently successfully treated and drug resistant tuberculosis is growing at 10% per year

We are currently exploring investment and collaboration options with a number of the worlds leading tuberculosis research scientists, who have discovered phytochemicals that appear to interact with existing drugs to produce a low cost and effective treatment that could counter drug resistant tuberculosis and it has been developed using pioneering genetic biotechnology processes